mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.03 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |